900000000000508004: Great Britain English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\GB English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GB English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Neoplasm of stomach	Preferred (foundation metadata concept)
+	Preferred (foundation metadata concept)
++	Preferred (foundation metadata concept)
+++	Preferred (foundation metadata concept)
++++	Preferred (foundation metadata concept)
0-5 mitoses per 10 HPF (score = 1)	Preferred (foundation metadata concept)
0-5 mitoses per 10 high power fields (score = 1)	Acceptable (foundation metadata concept)
0-5 mitoses per 10 high power fields (score = 1) (finding)	Preferred (foundation metadata concept)
1 or more mitotic figure per mm2	Preferred (foundation metadata concept)
1 or more mitotic figure per mm2 (finding)	Preferred (foundation metadata concept)
1,2-benzisothiazolin-3-one	Preferred (foundation metadata concept)
1,2-benzisothiazolin-3-one (substance)	Preferred (foundation metadata concept)
1,4-benzenediamine	Acceptable (foundation metadata concept)
1,4-butanedicarboxylic acid	Acceptable (foundation metadata concept)
1,4-phenylenediamine base	Acceptable (foundation metadata concept)
1-beta-D-Arabinofuranosylcytosine	Acceptable (foundation metadata concept)
1-phenylpropan-2-amine	Acceptable (foundation metadata concept)
10 or more mitotic figures per 10 HPF	Acceptable (foundation metadata concept)
10 or more mitotic figures per 10 high power field	Preferred (foundation metadata concept)
10 or more mitotic figures per 10 high power field (finding)	Preferred (foundation metadata concept)
10-20 mitoses per 10 HPF (score = 2)	Preferred (foundation metadata concept)
10-20 mitoses per 10 high power fields (score = 2)	Acceptable (foundation metadata concept)
10-20 mitoses per 10 high power fields (score = 2) (finding)	Preferred (foundation metadata concept)
12 hour urine specimen	Preferred (foundation metadata concept)
14-hydroxydihydrocodeinone	Acceptable (foundation metadata concept)
17-beta estradiol	Acceptable (foundation metadata concept)
1st trimester	Acceptable (foundation metadata concept)
2 dimethylaminoethanol	Acceptable (foundation metadata concept)
2 hour urine specimen	Preferred (foundation metadata concept)
2 hour urine specimen (specimen)	Preferred (foundation metadata concept)
2,4-hexadienoic acid	Acceptable (foundation metadata concept)
2,6-di-tert-butyl-p-cresol	Acceptable (foundation metadata concept)
2,6-ditert-butyl-4-cresol (BHT)	Acceptable (foundation metadata concept)
2,6-ditertiary-butyl-4-cresol (BHT)	Acceptable (foundation metadata concept)
2-amino-6-mercaptopurine	Acceptable (foundation metadata concept)
2-hydroxy-4-methoxybenzophenone	Acceptable (foundation metadata concept)
2-propylpentanoic acid	Acceptable (foundation metadata concept)
2-propylvaleric acid	Acceptable (foundation metadata concept)
2019 novel coronavirus	Acceptable (foundation metadata concept)
2019 novel coronavirus DNA plasmid encoding spike protein vaccine	Acceptable (foundation metadata concept)
2019 novel coronavirus antigen immunisation	Acceptable (foundation metadata concept)
2019 novel coronavirus antigen vaccination	Acceptable (foundation metadata concept)
2019 novel coronavirus antigen vaccine	Acceptable (foundation metadata concept)
2019 novel coronavirus inactivated whole antigen vaccine	Acceptable (foundation metadata concept)
2019 novel coronavirus mRNA vaccine	Acceptable (foundation metadata concept)
2019 novel coronavirus recombinant spike protein antigen vaccine	Acceptable (foundation metadata concept)
2019 novel coronavirus virus-like particle antigen vaccine	Acceptable (foundation metadata concept)
2019-nCoV	Acceptable (foundation metadata concept)
2019-nCoV antigen immunisation	Acceptable (foundation metadata concept)
2019-nCoV antigen vaccination	Acceptable (foundation metadata concept)
24 hour faeces specimen	Acceptable (foundation metadata concept)
24 hour stool specimen	Preferred (foundation metadata concept)
24 hour urine sample	Acceptable (foundation metadata concept)
24 hour urine specimen	Preferred (foundation metadata concept)
24 hour urine specimen (specimen)	Preferred (foundation metadata concept)
24 hour urine specimen collection	Acceptable (foundation metadata concept)
24H specimen	Acceptable (foundation metadata concept)
2H specimen	Acceptable (foundation metadata concept)
3 antigen Hepatitis B recombinant surface only vaccine product	Preferred (foundation metadata concept)
3TC	Acceptable (foundation metadata concept)
3rd nerve palsy	Acceptable (foundation metadata concept)
4-allyl-2-methoxyphenol	Acceptable (foundation metadata concept)
4-aminosalicylic acid	Acceptable (foundation metadata concept)
4-chloro-3,5-xylenol	Acceptable (foundation metadata concept)
48 hour faecal specimen	Acceptable (foundation metadata concept)
48 hour faeces specimen	Acceptable (foundation metadata concept)
48 hour stool specimen	Preferred (foundation metadata concept)
48 hour urine specimen	Preferred (foundation metadata concept)
4th nerve palsy	Acceptable (foundation metadata concept)
5-ASA	Acceptable (foundation metadata concept)
5-FC	Acceptable (foundation metadata concept)
5-Hydroxytryptamine measurement	Acceptable (foundation metadata concept)
5-aminosalicylic acid	Acceptable (foundation metadata concept)
5-fluorocytosine	Acceptable (foundation metadata concept)
5-fluorouracil	Acceptable (foundation metadata concept)
6-10 mitoses per 10 HPF (score = 2)	Preferred (foundation metadata concept)
6-10 mitoses per 10 high power fields	Acceptable (foundation metadata concept)
6-10 mitoses per 10 high power fields (score = 2)	Acceptable (foundation metadata concept)
6-10 mitoses per 10 high power fields (score = 2) (finding)	Preferred (foundation metadata concept)
6-MP	Acceptable (foundation metadata concept)
6-O-methylerythromycin	Acceptable (foundation metadata concept)
6-TG	Acceptable (foundation metadata concept)
6-mercaptopurine	Acceptable (foundation metadata concept)
6-phytase	Preferred (foundation metadata concept)
6-phytase (substance)	Preferred (foundation metadata concept)
6-thioguanine	Acceptable (foundation metadata concept)
70M specimen	Acceptable (foundation metadata concept)
72 hour urine specimen	Preferred (foundation metadata concept)
8 hour urine specimen	Preferred (foundation metadata concept)
< 4 mitoses/high power field	Preferred (foundation metadata concept)
< 4 mitoses/high power field (finding)	Preferred (foundation metadata concept)
> 4 mitoses/high power field	Acceptable (foundation metadata concept)
>10 mitoses per 10 HPF (score = 3)	Acceptable (foundation metadata concept)
>20 mitoses per 10 HPF (score = 3)	Acceptable (foundation metadata concept)
A - alphalipoproteinaemia neuropathy	Acceptable (foundation metadata concept)
A bilateral tonic-clonic epileptic seizure of more than 5 minutes duration. The seizure may be focal, generalised or unknown onset.	Preferred (foundation metadata concept)
A broad term that encompasses several types of imaging studies that use ionising radiation for visualisation of internal parts of the body using X-ray techniques, for example computed tomography.	Preferred (foundation metadata concept)
A cataract involving the nucleus of the lens	Preferred (foundation metadata concept)
A clinically oriented interview of a patient or someone familiar with the patient	Preferred (foundation metadata concept)
A complex mixture consisting of allergenic proteins derived from natural sources used for allergy treatment by subcutaneous or oral/sublingual route.	Preferred (foundation metadata concept)
A complex mixture consisting of allergenic proteins derived from natural sources. May be used for diagnosis or therapy. Extracts used for diagnosis have the same active ingredients as those used for therapy but may differ by concentration, diluent or other additives.	Preferred (foundation metadata concept)

Page 1 of 580 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001112010	Great Britain English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001113017	GB English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001114011	Great Britain English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)